The Patient Experience of Drug Side Effects in Rheumatoid Arthritis: Intriguing Data From an Exploratory Online Survey

Q2 Medicine

The Journal of rheumatology. Supplement Pub Date : 2022-06-15 DOI:10.3899/jrheum.220412

John M. Davis

引用次数: 2

Abstract

Understanding adverse events (AEs) of disease-modifying antirheumatic drugs (DMARDs) for treatment of rheumatoid arthritis (RA) is critical to both patients and clinicians. AEs-"side effects" from the patient perspective-contribute significantly to patients' disease experience by interfering with activities of daily living and quality of life (QOL).1.

查看原文本刊更多论文

类风湿关节炎患者对药物副作用的体验:一项探索性在线调查的有趣数据

了解改善疾病的抗风湿药物(DMARDs)治疗类风湿性关节炎(RA)的不良事件(ae)对患者和临床医生都至关重要。ae——从患者的角度来看的“副作用”——通过干扰日常生活活动和生活质量(QOL)，对患者的疾病经历有重要影响。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

The Journal of rheumatology. Supplement Medicine-Medicine (all)

自引率

0.00%

发文量

期刊介绍： The Journal of Rheumatology is a monthly international serial edited by Duncan A. Gordon, The Journal features research articles on clinical subjects from scientists working in rheumatology and related fields, as well as proceedings of meetings as supplements to regular issues. Highlights of our 36 years serving Rheumatology include: groundbreaking and provocative editorials such as "Inverting the Pyramid," renowned Pediatric Rheumatology, proceedings of OMERACT and the Canadian Rheumatology Association, Cochrane Musculoskeletal Reviews, and supplements on emerging therapies.